NCT02119780View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region

NAUnknownINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Conditions
Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region
Interventions
DEVICE

YVOIRE® contour

YVOIRE® contour injection into the anteromedial malar region

DEVICE

Restylane SubQ™

Restylane SubQ™ injection into the anteromedial malar region

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY

NCT02119780 - Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected Into the Anteromedial Malar Region | Biotech Hunter | Biotech Hunter